UK Medicines Information
AWMSG issues Final Appraisal Recommendation on linaclotide (Constella®)
Information type:
Drug best practice guidance
Source:
All Wales Medicines Strategy Group
Specialities:
Mental health and illness
Summary
Linaclotide is recommended as an option for restricted use within NHS Wales for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation in adults who have not responded adequately to or cannot tolerate antispasmodics and/or laxatives.
UKMi comment
The appraisal reports and clinical expert summary can be accessed from the link below
Related links:
Link to related documents